Skip to content

Effect of transcutaneous electrical acupoint stimulation pretreatment on the recovery of gastrointestinal function in patients following laparoscopic colorectal carcinomas operation: A Randomized Controlled Trial

Effect of transcutaneous electrical acupoint stimulation pretreatment on the recovery of gastrointestinal function in patients following laparoscopic colorectal carcinomas operation: A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005306
Enrollment
Unknown
Registered
2021-09-14
Start date
2021-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal carcinomas

Interventions

Control:Transcutaneous electrical acupoint stimulation (TEAS)

Sponsors

the First Affiliated Hospital of the University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Patients who underwent laparoscopic colorectal surgery under general anesthesia, 18 to 75 years old, 18 = body mass index (BMI) = 30, American Society of Anesthesiologists (ASA) Physical Status classes I or II; (2) Pathological report showed the intestinal malignant tumor. This study enrolled the participants with a continuous pattern.

Exclusion criteria

Exclusion criteria: (1) Patients who are unable to defecate due to gastrointestinal fistulotomy; (2) Patients with infections on the electrical stimulation sites;(3) Patients with implanted cardiac pacemakers; (4) Patients with nerve damage;(5) Patients who had participated in other clinical experiments within the past 4 weeks; (6) Patients who have a long history of alcoholism, opioid addiction, or dependence;(7) Patients who had severe central nervous system disease and severe mental illness before the operation; (8) Patients who were considered unsuitable for this experiment by the investigator.

Design outcomes

Primary

MeasureTime frame
the concentration of serum gastrin-17;

Countries

China

Contacts

Public ContactYanhu,Xie
xyh200701@sina.cn13956013081

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026